Open access · CC-BY
via OpenAlex
Effects of senolytic interventions on cognitive outcomes in animal models of aging and neurodegenerative disease: A systematic review
Dharmendra Kumar Gupta, Chaudhuri Arunima
Journal of Krishna Institute of Medical Sciences University · 2026
Cellular senescence
Chronic inflammation
Senolytics
Human
Systematic review
Preclinical / animal
Review
Abstract
Background: Cellular senescence(definition) has gained increasing attention as a biological process that contributes to brain aging, neuroinflammation, and the progression of neurodegenerative disorders. The accumulation of senescent cells and their pro-inflammatory secretory profile may adversely affect neuronal function and cognitive performance. Senolytic therapies, which selectively remove senescent cells, have therefore emerged as potential interventions for age-related cognitive impairment. Aim and Objectives: To systematically evaluate preclinical evidence regarding the effects of senolytic interventions on cognitive outcomes in animal models of aging and neurodegenerative disease. Methods: A systematic review was conducted according to PRISMA 2020 recommendations. Electronic searches of PubMed and Scopus were performed up to December 31, 2025. Original in vivo studies investigating senolytic interventions and reporting cognitive or behavioural outcomes in animal models of aging or neurodegeneration were eligible for inclusion. Results: Seven eligible studies were included in the qualitative synthesis. The studies employed diverse rodent models, including naturally aged animals, Alzheimer's disease models, and traumatic brain injury models. Interventions evaluated included dasatinib plus quercetin, fisetin, ABT-263 (navitoclax), and genetic elimination of senescent cells. Across studies, senolytic treatment was generally associated with improved learning, memory, and other cognitive functions. Several investigations also reported reductions in neuroinflammatory markers and pathological features associated with neurodegeneration. However, methodological heterogeneity and incomplete reporting of randomization and blinding limited direct comparison among studies. Conclusion: Current preclinical evidence suggests that senolytic strategies may ameliorate cognitive deficits associated with aging and neurodegenerative disorders. Nevertheless, the available evidence remains limited, and additional rigorously designed animal studies are required before clinical translation can be confidently pursued.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.5281/zenodo.21787976
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Gupta, D.K., & Arunima, C. (2026). Effects of senolytic interventions on cognitive outcomes in animal models of aging and neurodegenerative disease: A systematic review. <em>Journal of Krishna Institute of Medical Sciences University</em>. https://doi.org/10.5281/zenodo.21787976
Vancouver
Gupta DK, Arunima C. Effects of senolytic interventions on cognitive outcomes in animal models of aging and neurodegenerative disease: A systematic review. Journal of Krishna Institute of Medical Sciences University. 2026. doi:10.5281/zenodo.21787976.
BibTeX
@article{dharmendra2026Effect,
title = {Effects of senolytic interventions on cognitive outcomes in animal models of aging and neurodegenerative disease: A systematic review},
author = {Dharmendra Kumar Gupta and Chaudhuri Arunima},
journal = {Journal of Krishna Institute of Medical Sciences University},
year = {2026},
doi = {10.5281/zenodo.21787976},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
2026
Open access · OA
Senolytic therapy in Alzheimer’s disease: clinical evidence and biomarkers
Degenerative Neurological and Neuromuscular Disease 2026
Open access · CC-BY
Spermidine in Alzheimer’s Disease: Evidence from Animal Models and Human Studies
Dementia & Neuropsychologia 2016
Open access · CC-BY
Subjective cognitive decline: The first clinical manifestation of Alzheimer's disease?
Degenerative neurological and neuromuscular disease 2026
Open access · OA
Spermidine in Alzheimer's Disease: Evidence from Animal Models and Human Studies.
Burdur Mehmet Akif Ersoy University 2025
Open access · US-GOV
Evaluation of the Effects of Elderberry-Based Anthocyanin-Enriched Functional Chewing Gum on Cognitive Functions and Oral Microbiota in Older Adults: A Double-Blind, Randomized Controlled Trial
Frontiers in Medicine 2019
Open access · CC-BY